Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy
- PMID: 34255346
- PMCID: PMC8426667
- DOI: 10.1002/jmv.27199
Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy
Abstract
Measurement of the population's general knowledge of the coronavirus vaccine is very important to improve public acceptance and decrease vaccine hesitancy in confronting the disease. This study aimed to evaluate the knowledge, attitude, and practices of the participants towards the coronavirus vaccine. Data were collected using an online survey, in the form of a structured questionnaire, conducted during April-May 2021 in Egypt, and subjects from all over Egypt participated. The questionnaire was divided into three parts to assess the knowledge and attitude regarding coronavirus. The first part was to assess participants' experience about coronavirus infection (eight items), the second was to assess the health beliefs about coronavirus and vaccine (16 items) and the third was to assess general knowledge, attitude, and practices of the participants towards vaccine (28 items). A total of 871 (465 females) participants participated, 81% of them were still committed to the precautionary measures for protection. Eighty-eight percent of them accepted to take the vaccine. Eighty-three percent of the participants answered that they will encourage family, friends, and colleagues to get the vaccine. Ninety-four percent knew that the coronavirus vaccine provides immunity against infection for a period of 6-12 months. 91.9% believed that the current infection with coronavirus is one of the main contraindications to vaccination. Eighty-nine percent believed that both pregnant women and chronic disease patients can get vaccinated and also that there is no specific age for a specific type of vaccination. Ninety-four percent of them knew that subjects taking immunosuppressive drugs should be prescribed Sinopharm, not AstraZeneca vaccine. The median score of this survey was 20/22 regarding knowledge about the coronavirus vaccine. Overall, the study participants had good knowledge about the coronavirus vaccine and accepted to take the vaccine, which indicates the highly commendable efforts to confront the coronavirus.
Keywords: COVID-19 vaccine; Egypt; FDA; public awareness.
© 2021 Wiley Periodicals LLC.
Similar articles
-
A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.J Assoc Physicians India. 2023 Sep;71(9):19-27. doi: 10.59556/japi.71.0335. J Assoc Physicians India. 2023. PMID: 38700297
-
COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.PLoS One. 2021 Mar 24;16(3):e0248892. doi: 10.1371/journal.pone.0248892. eCollection 2021. PLoS One. 2021. PMID: 33760836 Free PMC article.
-
High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.Epidemiol Infect. 2021 May 11;149:e123. doi: 10.1017/S0950268821001114. Epidemiol Infect. 2021. PMID: 33972001 Free PMC article.
-
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.J Integr Med. 2022 Jan;20(1):34-44. doi: 10.1016/j.joim.2021.10.004. Epub 2021 Oct 26. J Integr Med. 2022. PMID: 34774463 Free PMC article. Review.
-
Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy.Mayo Clin Proc. 2021 Mar;96(3):699-707. doi: 10.1016/j.mayocp.2020.12.024. Epub 2020 Dec 30. Mayo Clin Proc. 2021. PMID: 33673921 Free PMC article. Review.
Cited by
-
Factors Influencing Decision Making Regarding the Acceptance of the COVID-19 Vaccination in Egypt: A Cross-Sectional Study in an Urban, Well-Educated Sample.Vaccines (Basel). 2021 Dec 24;10(1):20. doi: 10.3390/vaccines10010020. Vaccines (Basel). 2021. PMID: 35062681 Free PMC article.
-
Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population.Vaccines (Basel). 2022 Jan 12;10(1):109. doi: 10.3390/vaccines10010109. Vaccines (Basel). 2022. PMID: 35062770 Free PMC article.
-
Impact of COVID-19 Vaccine Misinformation on Social Media Virality: Content Analysis of Message Themes and Writing Strategies.J Med Internet Res. 2022 Jul 6;24(7):e37806. doi: 10.2196/37806. J Med Internet Res. 2022. PMID: 35731969 Free PMC article.
-
COVID-19 vaccination hesitancy among Malawians: a scoping review.Syst Rev. 2024 Feb 28;13(1):77. doi: 10.1186/s13643-024-02499-z. Syst Rev. 2024. PMID: 38419126 Free PMC article.
-
Social Vulnerability and COVID-19 Vaccine in Spain.Int J Environ Res Public Health. 2022 Oct 27;19(21):14013. doi: 10.3390/ijerph192114013. Int J Environ Res Public Health. 2022. PMID: 36360892 Free PMC article.
References
-
- Elgendy MO, Abd Elmawla MN, Abdel Hamied AM, El Gendy SO, Abdelrahim MEA. COVID‐19 patients and contacted person awareness about home quarantine instructions. Int J Clin Pract. 2021;75(4):e13810. - PubMed
-
- La V‐P, Pham TH, Ho MT, et al. Policy response, social media and science journalism for the sustainability of the public health system amid the COVID‐19 outbreak. Sustainability. 2020;12(7):2931.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous